§ Federal grant opportunity · PAR-27-076
Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)
National Institutes of Health is accepting applications for Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional). The deadline is July 7, 2028 and the published award range is $499K.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- July 7, 2028
- Award range
- $499K
- Eligibility
- county governments, small businesses, other native american tribal organizations, other, private institutions of higher education, independent school districts, for profit organizations other than small businesses, city or township governments, special district governments, public and state institutions of higher education, federally recognized native american tribal governments, nonprofits non higher education with 501c3, public and indian housing authorities, nonprofits non higher education without 501c3, state governments
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- PAR-27-076
Program overview
This NOFO encourages applications for the Lasker Clinical Research Scholars Program. The program supports the research activities of clinical researchers during the early stages of their independent careers as they work to improve human health. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker Scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research institute, or can remain as an investigator within the intramural program.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before July 7, 2028, allowing time for registration and validation.
Related grant opportunities
- Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
- BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
- Defense Security Cooperation University - Research Grants
- Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.